The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say ...
Novo Nordisk’s Rybelsus (oral semaglutide) has failed to demonstrate efficacy in a late-stage trial in Alzheimer’s disease, denting hopes of glucagon-like peptide-1 receptor agonists (GLP-1RAs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results